Thrombopoietin (TPO) induces c-myc expression through a PI3K- and MAPK-dependent pathway that is not mediated by Akt, PKCzeta or mTOR in TPO-dependent cell lines and primary megakaryocytes.

scientific article published on 27 December 2005

Thrombopoietin (TPO) induces c-myc expression through a PI3K- and MAPK-dependent pathway that is not mediated by Akt, PKCzeta or mTOR in TPO-dependent cell lines and primary megakaryocytes. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CELLSIG.2005.09.010
P698PubMed publication ID16380230

P50authorSupanthitra ChanprasertQ81887247
P2093author name stringKenneth Kaushansky
Norma E Fox
Amy E Geddis
Charlene Barroga
P433issue8
P1104number of pages7
P304page(s)1212-1218
P577publication date2005-12-27
P1433published inCellular SignallingQ1524097
P1476titleThrombopoietin (TPO) induces c-myc expression through a PI3K- and MAPK-dependent pathway that is not mediated by Akt, PKCzeta or mTOR in TPO-dependent cell lines and primary megakaryocytes
P478volume18

Reverse relations

cites work (P2860)
Q30841144A network-based method for mechanistic investigation of Shexiang Baoxin Pill's treatment of cardiovascular diseases.
Q28505575Calcium- and integrin-binding protein 1 regulates megakaryocyte ploidy, adhesion, and migration
Q93541751Communication between bone marrow niches in normal bone marrow function and during hemopathies progression
Q34721025Complex interactions in EML cell stimulation by stem cell factor and IL-3
Q38187494Ex vivo production of platelets from stem cells
Q34219541Gender dependence for a subset of the low-abundance signaling proteome in human platelets
Q33393364Induced pluripotent stem cell-derived human platelets: one step closer to the clinic
Q46387376Lesion-targeted thrombopoietin potentiates vasculogenesis by enhancing motility and enlivenment of transplanted endothelial progenitor cells via activation of Akt/mTOR/p70S6kinase signaling pathway
Q33407003Long-term mTOR inhibitors administration evokes altered calcium homeostasis and platelet dysfunction in kidney transplant patients.
Q33424186Manipulating megakaryocytes to manufacture platelets ex vivo
Q24612339Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model
Q33383468Pathobiology of secondary immune thrombocytopenia
Q27026899Pluripotent stem cells reveal the developmental biology of human megakaryocytes and provide a source of platelets for clinical application
Q43010381Scalable generation of universal platelets from human induced pluripotent stem cells.
Q54696546The role of MAPK-ERK pathway in 67-kDa laminin receptor-induced FasL expression in human cholangiocarcinoma cells.
Q27008221The role of the JAK-STAT pathway and related signal cascades in telomerase activation during the development of hematologic malignancies
Q50897596Timing and expression level of protein kinase C epsilon regulate the megakaryocytic differentiation of human CD34 cells.
Q33392928Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells

Search more.